Erlotev

Erlotev is an oral medication containing Erlotinib, used for targeted therapy in certain cancer treatments. It works by inhibiting specific proteins to slow tumor growth.

Erlotev is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It targets epidermal growth factor receptors (EGFR) to interfere with cancer cell growth. Patients often wonder, 'What is Erlotinib used for?' It is typically prescribed for advanced or metastatic cancers where other treatments have failed.

Common effects of Erlotev may include skin rash, diarrhea, and fatigue. Some users also report loss of appetite and nausea. These effects vary among individuals and are not experienced by everyone.

Erlotev should be handled with care, especially by pregnant women or those planning to become pregnant. It is important to follow healthcare provider instructions and report any severe side effects promptly. Store in a cool, dry place away from direct sunlight.

Erlotev may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It is advisable to avoid grapefruit and grapefruit juice, as they can affect the drug's effectiveness. Always consult a healthcare provider before starting any new medication.